When was OriGene founded?

OriGene was founded in 1996 and raised its 1st funding round 8 years after it was founded.

Where is OriGene located?

OriGene is headquartered in Rockville, United States. It is registered at Rockville, Maryland.

How many employees does OriGene have?

As of Sep 30, 2026, the latest employee count at OriGene is 131.

Is OriGene a funded company?

OriGene is a funded company, having raised a total of $69.6M across 11 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 23, 2004.

When was the latest funding round of OriGene?

OriGene's latest funding was a $***** Series D round on Jun 09, 2015, with participation from 3 investors.

Where does OriGene rank among its competitors?

OriGene ranks 23rd amongst 1193 active competitors, of which 63 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of OriGene?

OriGene's top competitors include Abcam, Meridian Bioscience and Sino Biological. Among them, BioLamina secured the most recent funding round in April, 2026.

OriGene - 2026 Company Profile, Funding & Competitors

OriGene is a series D company based in Rockville (United States), founded in 1996. It operates as a Provider and manufacturer of proteins, antibodies, and other molecular tools for research applications. OriGene has raised $69.6M in funding from investors like IDG Capital, Merieux Developement and Zero2IPO Ventures. The company has 1193 active competitors, including 63 funded and 129 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Sino Biological.

Company Details

OriGene Technologies is focused on developing proteins, antibodies, and other molecular tools to support the academic, pharmaceutical, and biotech companies in their research of gene functions and drug discovery. Its product lines include the large cDNA and shRNA clone collections, about 5k purified human proteins, monoclonal antibodies (TrueMAB), 140k validated human tissues, and protein microarray products. It also provides a range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from the Company's tissue collection.

Website: origene.com
Social
Email ID: *****@origene.com
Registered Address: Rockville, Maryland

Key Metrics

Founded Year

1996

Location

Rockville, United States

Stage

Series D

Total Funding

$69.6M in 11 rounds

Latest Funding Round

Series D, Jun 09, 2015, $*****

Investors

IDG Capital & 14 more

Ranked

23^rd among 1193 active competitors

Employee Count

131 as on Sep 30, 2026

Investment & Acquisitions

biocheckinc.com & 1 more

Similar Companies

Abcam & 1365 more

View OriGene's full profile

OriGene is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Origene Technologies, Inc. CIN: 650626270 , United States, Active	Jun 03, 1996	-	159 (As on Dec 31, 2024)	-

OriGene has raised a total funding of $69.6M over 11 rounds. Its first funding round was on Sep 23, 2004. Its latest funding round was a Series D round on Jun 09, 2015 for $*****. 3 investors participated in its latest round. OriGene has 15 institutional investors.

Here is the list of recent funding rounds of OriGene:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 09, 2015	7996247	Series D	7969554	3756639	1062155	6578962
Mar 10, 2014	8085651	Series C	1341480	6620284	9453276	2786844
Mar 19, 2013	9508299	Series C	7544472	8994689	5840555	Qiming Venture Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of OriGene's funding rounds and investors

OriGene's employee count trend

OriGene has 131 employees as of Sep 26. Here is OriGene's employee count trend over the years:

Uncover OriGene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OriGene include Abcam, Meridian Bioscience and Sino Biological. Here is the list of Top 10 competitors of OriGene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	73/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	67/100
3rd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	63/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	61/100
7th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	58/100
8th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	58/100
9th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 2 others	58/100
10th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
23rd	OriGene 1996, Rockville (United States), Series D	Provider and manufacturer of proteins, antibodies, and other molecular tools for research applications	$69.6M	Kleiner Perkins, Cathay Capital & 13 others	50/100